Alzheimerโs disease, whichย is expected to have affected about 6.7 million patients in the U.S. in 2023, results in a substantial loss of brain cells. But the events that cause neuron death are poorly understood.
A new Northwestern Medicine study shows that RNA interference may play a key role in Alzheimerโs. For the first time, scientists have identified short strands of toxic RNAs that contribute to brain cell death and DNA damage in Alzheimerโs and aged brains. Short strands of protective RNAs are decreased during aging, the scientists report, which may allow Alzheimerโs to develop.
The study also found that older individuals with a superior memory capacity (known as SuperAgers) have higher amounts of protective short RNA strands in their brain cells. SuperAgers are individuals aged 80 and older with a memory capacity of individuals 20 to 30 years younger.
โNobody has ever connected the activities of RNAs to Alzheimerโs,โ said corresponding study author Marcus Peter, the Tom D. Spies Professor of Cancer Metabolism at Northwestern University Feinberg School of Medicine. โWe found that in aging brain cells, the balance between toxic and protective sRNAs shifts toward toxic ones.โ
Sign up for the Daily Dose Newsletter and get every morning’s best science news from around the web delivered straight to your inbox? It’s easy like Sunday morning.
The paper will be published Jan.18 in Nature Communications.
Relevance beyond Alzheimerโs disease
The Northwestern discovery may have relevance beyond Alzheimerโs. โOur data provide a new explanation for why, in almost all neurodegenerative diseases, affected individuals have decades of symptom free life and then the disease starts to set in gradually as cells lose their protection with age,โ Peter said.
New avenue for treatment
The findings also point to a new way for treating Alzheimerโs and potentially other neurodegenerative diseases.
Alzheimerโs is characterized by a progressive occurrence of amyloid-beta plaques, tau neurofibrillary tangles, scarring and ultimate brain cell death.
โThe overwhelming investment in Alzheimerโs drug discovery has been focused on two mechanisms: reducing amyloid plaque load in the brain โ which is the hallmark of Alzheimerโs diagnosis and 70 to 80% of the effort โ and preventing tau phosphorylation or tangles,โ Peter said. โHowever, treatments aimed at reducing amyloid plaques have not yet resulted in an effective treatment that is well tolerated.
โOur data support the idea that stabilizing or increasing the amount of protective short RNAs in the brain could be an entirely new approach to halt or delay Alzheimerโs or neurodegeneration in general.โ
Such drugs exist, Peter said, but they would need to be tested in animal models and improved.
The next step in Peter’s research is to determine in different animal and cellular models (as well as in brains from Alzheimerโs patients) the exact contribution of toxic sRNAs to the cell death seen in the disease and screen for better compounds that would selectively increase the level of protective sRNAs or block the action of the toxic ones.
What are toxic and protective short RNAs?
All our gene information is stored in form of DNA in the nucleus of every cell. To turn this gene information into the building blocks of life, DNA needs to be converted into RNA which is used by cell machinery to produce proteins. RNA is essential for most biological functions.
In addition to these long coding RNAs, there are large numbers of short RNAs (sRNAs), which do not code for proteins. They have other critical functions in the cell. One class of such sRNAs suppresses long coding RNAs through a process called RNA interference that results in the silencing of the proteins that the long RNAs code for.
Peter and colleagues have now identified very short sequences present in some of these sRNAs that when present can kill cells by blocking production of proteins required for cells to survive resulting in cell death. Their data suggest that these toxic sRNAs are involved in the death of neurons which contributes to the development of Alzheimerโs disease.
The toxic sRNAs are normally inhibited by protective sRNAs. One type of sRNA is called microRNAs. While microRNAs play multiple important regulatory roles in cells, they are also the main species of protective sRNAs. They are the equivalent of guards that prevent the toxic sRNAs from entering the cellular machinery that executes RNA interference. But the guardsโ numbers decrease with aging, thus allowing the toxic sRNAs to damage the cells.
IMAGE CREDIT: NASA.
If you enjoy the content we create and would like to support us, please consider becoming a patron on Patreon! By joining our community, you’ll gain access to exclusive perks such as early access to our latest content, behind-the-scenes updates, and the ability to submit questions and suggest topics for us to cover. Your support will enable us to continue creating high-quality content and reach a wider audience.
Join us on Patreon today and let’s work together to create more amazing content! https://www.patreon.com/ScientificInquirer
Leave a Reply